NIPBL helps guide early growth by controlling when many other genes turn on and off, especially during development before birth. This gene plays an important role in organizing chromosomes and helping cells copy and divide their DNA in an orderly way. When the NIPBL gene does not work properly, it can cause Cornelia de Lange syndrome, which may affect growth, learning, behavior, and the shape of the face, hands, or arms. It is mainly known in medicine rather than popular culture.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes carry the directions for producing proteins, the parts of cells that do much of the work. Other genes mostly help govern when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in greater depth, you can learn more in LearnHub.
Overview
NIPBLGene function
What if the gene works
The NIPBL gene helps cells organize DNA and control which genes are turned on or off. It also supports normal cell division by helping chromosomes separate in an orderly way.
Risk
What if the gene does not work
Variants in the NIPBL gene often cause Cornelia de Lange syndrome. People may have growth and developmental differences, learning difficulties, and limb or organ changes; milder and severe variants can influence how early signs appear and how broad they are.
Treatment
What does that mean for your treatment
No treatment or drug choice specific to a pathogenic variant in the NIPBL gene is currently established. Care is tailored to the person's symptoms and daily needs, and the NIPBL gene is being studied in early-stage research as a possible target for future therapies.
Conditions associated with NIPBL
Gene function
What if the gene works
NIPBL helps your cells manage DNA in an orderly way so genes turn on at the right time and chromosomes stay coordinated during cell division. It does this mainly by helping a protein group called cohesin attach to DNA. Understanding this role helps explain how normal growth and development stay on track.
The NIPBL gene helps place cohesin, a protein group, onto DNA. This gives cells a reliable way to organize long DNA strands and use them in a controlled way.
During cell division, cohesin helps paired chromosomes stay together until the right moment. NIPBL supports this timing so each new cell receives a balanced set of genetic material.
By helping cohesin sit in the right places on DNA, NIPBL supports when and how strongly many genes are used. This is a key part of how the NIPBL gene helps cells divide and guide early growth.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help explain normal differences between people, such as appearance, metabolism, or how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the NIPBL gene can lower the amount of NIPBL protein made or change its shape, so it cannot work properly with other proteins that control gene activity during early development. This helps explain how NIPBL gene variants affect function at the cellular level. Some variants leave partial activity, while more disruptive variants greatly reduce or stop protein function. In Cornelia de Lange syndrome, stronger loss of function is often linked to earlier and more pronounced features.
How variants are linked to conditions
Pathogenic variants in the NIPBL gene are the most common known cause of Cornelia de Lange syndrome, a genetic condition linked with differences in growth, development, learning, and sometimes the limbs. The NIPBL gene and Cornelia de Lange syndrome are closely connected in clinical genetics, and finding a pathogenic variant can confirm the diagnosis. Some people have milder features, while others are more noticeably affected.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology. Most do not directly affect health and simply contribute to the natural diversity seen among people. For many genes, having a variant linked to a condition suggests a possible association rather than a confirmed diagnosis, especially when several genes and environmental factors also play a part. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For NIPBL, risk is usually driven by whether a disease-causing gene change is present, not by lifestyle. Most cases happen for the first time in a child, but risk can be higher if a parent carries the variant or has mosaicism, meaning the change is present in some of their egg or sperm cells.
Inheritance of NIPBL variants
NIPBL-related conditions are usually inherited in an autosomal dominant pattern, which means one altered copy of the NIPBL gene can be enough to cause the condition. For families asking how NIPBL variants are inherited, a parent who carries the variant has a 50% chance of passing it on in each pregnancy. Many people with a NIPBL-related condition have a new (de novo) variant that was not inherited from either parent. In some families, a parent may carry the variant in some of their cells, which can affect recurrence risk.
What does my NIPBL result mean for my family?
For NIPBL, a disease-causing result is usually linked to a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. In many families, though, the change starts new in one person and is not found in either parent. Even so, family members can still have questions about who else in the family may be affected or carry it.
Genetic information
Genetic testing
How you find out about variants
To look for a variant in the NIPBL gene, doctors use genetic testing for variants in the NIPBL gene, usually on a blood or saliva sample. The lab reads the DNA code and may also check for missing or extra pieces of the gene. Results may find a disease causing variant, find no relevant variant, or show an unclear result.
When should I consider getting a genetic test?
Genetic testing for the NIPBL gene may be worth discussing if a child has signs of Cornelia de Lange syndrome, such as slow growth, feeding problems, developmental delay, distinctive facial features, or limb differences. It can also be important when this condition is known or suspected in the family, or after a pregnancy scan shows related findings.
A genetic result is only one part of your health story
A genetic result can be very informative, but how much it reveals depends on the condition and the type of variant involved. Many other factors also shape how the body works over time, including age, medical history, environment, and lifestyle. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down a drug more slowly or more quickly than expected, so the same treatment may work differently from one person to another. These inherited differences are common and can influence how well a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics explores how differences in genes can shape a person’s response to medicines. It studies links between genes and drugs to help explain why the same treatment may affect people in different ways. With many medications, genes can influence how strongly a drug works or how the body processes it. This understanding can support treatment decisions that are better informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the NIPBL gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor or pharmacist.
History
Cornelia de Lange syndrome was first described in children by Dutch pediatrician Cornelia de Lange in 1933, although similar features had been noted earlier. For many years, doctors recognized the condition by its physical pattern alone, without knowing the genetic cause. In 2004, researchers identified variants in the NIPBL gene as a major cause, which marked a turning point in understanding the condition at the DNA level. From these first observations, research expanded steadily, and NIPBL became the first and most commonly implicated gene linked to Cornelia de Lange syndrome. This discovery helped clarify why people with the condition can have a wide range of features and encouraged broader genetic testing in affected families.